Sorrento Therapeutics

$6.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+1.77%) Today
-$0.02 (-0.29%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SRNE and other stocks, options, and ETFs commission-free!

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA. The listed name for SRNE is Sorrento Therapeutics, Inc. Common Stock.

CEO
Henry H. Ji
Employees
310
Headquarters
San Diego, California
Founded
2006
Market Cap
1.81B
Price-Earnings Ratio
Dividend Yield
Average Volume
13.26M
High Today
$7.23
Low Today
$6.58
Open Price
$6.58
Volume
11.96M
52 Week High
$19.39
52 Week Low
$1.55

Collections

SRNE Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, After Hours

You May Also Like